Cancer Research The Future of Cancer Research: Science and Patient Impact
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 59, 3264-3270, July 1, 1999]
© 1999 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Coppola, D.
Right arrow Articles by Nicosia, S. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coppola, D.
Right arrow Articles by Nicosia, S. V.
[Cancer Research 59, 3264-3270, July 1, 1999]
© 1999 American Association for Cancer Research


Tumor Biology

The Insulin-like Growth Factor 1 Receptor Induces Transformation and Tumorigenicity of Ovarian Mesothelial Cells and Down-Regulates Their Fas-Receptor Expression

Domenico Coppola1, Beatrice Saunders, Ling Fu, Weiguang Mao and Santo V. Nicosia

Department of Pathology, University of South Florida, College of Medicine, and H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612-9497

Cell proliferation and papillogenesis are growth factor-sensitive events in the ovarian mesothelium, the tissue source of ovarian epithelial cancer. To further investigate the regulation of cell proliferation in this tissue, rabbit ovarian mesothelial cells (OMC) were transfected in vitro with a CVN expression vector carrying the human gene for insulin-like growth factor 1 receptor (IGF-1R). The growth characteristics of IGF-1R transfectants (OMIR) and their response to IGF-1 were then compared with those of OMC in serumless HL-1 cultures. OMIR cells formed epithelial-like colonies and, even when nonconfluent, produced tridimensional structures reminiscent of papillae seen in ovarian serous epithelial tumors. After 3 and 7 days of exposure to IGF-1, OMIR cells grew ~20-fold (P < 0.05), and papillogenesis was 15- to 25-fold over similar events in OMC, respectively. Exposure to treatment with antisense oligonucleotides against IGF-1R mRNA inhibited OMIR growth rate by 70%. Western immunoblotting and flow cytometry revealed higher expression of IGF-1R in OMIR cells than in OMC. The reverse was true when Fas-receptor expression was evaluated. OMIR cells were clonogenic in 15% serum-rich soft agar assay (OMIR:OMC colony-forming ratio 150–200:1), and tumorigenic in nude mice in which high-grade carcinomas with occasional lung metastases were observed. These data suggest that IGF-1R plays a role in ovarian epithelial carcinogenesis. The overexpression of this receptor induces transformation and morphogenesis of OMCs via an autocrine mechanism. IGF-1R may down-regulate the Fas expression rendering transformed ovarian mesothelial cells resistant to apoptosis.




This article has been cited by other articles:


Home page
Endocr Relat CancerHome page
P. H M Peeters, A. Lukanova, N. Allen, F. Berrino, T. Key, L. Dossus, S. Rinaldi, C. H van Gils, H B. Bueno-de-Mesquita, H. Boeing, et al.
Serum IGF-I, its major binding protein (IGFBP-3) and epithelial ovarian cancer risk: the European Prospective Investigation into Cancer and Nutrition (EPIC)
Endocr. Relat. Cancer, March 1, 2007; 14(1): 81 - 90.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
L. Lu, D. Katsaros, A. Wiley, I. A. Rigault de la Longrais, H. A. Risch, M. Puopolo, and H. Yu
The Relationship of Insulin-Like Growth Factor-II, Insulin-Like Growth Factor Binding Protein-3, and Estrogen Receptor-{alpha} Expression to Disease Progression in Epithelial Ovarian Cancer
Clin. Cancer Res., February 15, 2006; 12(4): 1208 - 1214.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. Lukanova and R. Kaaks
Endogenous Hormones and Ovarian Cancer: Epidemiology and Current Hypotheses
Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 98 - 107.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
L. C. Shaw, A. Afzal, A. S. Lewin, A. M. Timmers, P. E. Spoerri, and M. B. Grant
Decreased Expression of the Insulin-like Growth Factor 1 Receptor by Ribozyme Cleavage
Invest. Ophthalmol. Vis. Sci., September 1, 2003; 44(9): 4105 - 4113.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
D. Del Bufalo, V. Di Castro, A. Biroccio, M. Varmi, D. Salani, L. Rosano, D. Trisciuoglio, F. Spinella, and A. Bagnato
Endothelin-1 Protects Ovarian Carcinoma Cells against Paclitaxel-Induced Apoptosis: Requirement for Akt Activation
Mol. Pharmacol., March 1, 2002; 61(3): 524 - 532.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
N. Auersperg, A. S. T. Wong, K.-C. Choi, S. K. Kang, and P. C. K. Leung
Ovarian Surface Epithelium: Biology, Endocrinology, and Pathology
Endocr. Rev., April 1, 2001; 22(2): 255 - 288.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
H. M. Khandwala, I. E. McCutcheon, A. Flyvbjerg, and K. E. Friend
The Effects of Insulin-Like Growth Factors on Tumorigenesis and Neoplastic Growth
Endocr. Rev., June 1, 2000; 21(3): 215 - 244.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.